Crystal structure of opsin in its G-protein-interacting conformation
The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
Opsin, the ligand-free form of the G-protein-coupled receptor rhodopsin, at low pH adopts a conformationally distinct, active G-protein-binding state known as Ops*. A synthetic peptide derived from the main binding site of the heterotrimeric G protein-the carboxy terminus of the alpha-subunit (GalphaCT)-stabilizes Ops*. Here we present the 3.2 A crystal structure of the bovine Ops*-GalphaCT peptide complex. GalphaCT binds to a site in opsin that is opened by an outward tilt of transmembrane helix (TM) 6, a pairing of TM5 and TM6, and a restructured TM7-helix 8 kink. Contacts along the inner surface of TM5 and TM6 induce an alpha-helical conformation in GalphaCT with a C-terminal reverse turn. Main-chain carbonyl groups in the reverse turn constitute the centre of a hydrogen-bonded network, which links the two receptor regions containing the conserved E(D)RY and NPxxY(x)(5,6)F motifs. On the basis of the Ops*-GalphaCT structure and known conformational changes in Galpha, we discuss signal transfer from the receptor to the G protein nucleotide-binding site.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The crystal structure of opsin,370 an opsin structure with another retinoid bound,371 and mutagenesis studies372 all suggest an escape and entrance route for retinal.”
From Chemistry of the Retinoid (Visual) Cycle (2014) · cites this paper as [370]
Citations
Cites
1 retracted
Johnston, C. A., & Siderovski, D. P. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608599104 · Cited by 38
Retracted[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
The PyMOL Molecular Graphics System
DeLano, W. L. (2002) · Medical Entomology and Zoology · Cited by 18,147
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination
Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J. S., Kuszewski, J., Nilges, M., Pannu, N. S., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,715
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., et al. (2000) · Science · doi:10.1126/science.289.5480.739 · Cited by 5,637
High-Resolution Crystal Structure of an Engineered Human β 2 -Adrenergic G Protein–Coupled Receptor
Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., et al. (2007) · Science · doi:10.1126/science.1150577 · Cited by 3,264
Cited by
The structure and function of G-protein-coupled receptors
Rosenbaum, D. M., Rasmussen, S. G. F., & Kobilka, B. K. (2009) · Nature · doi:10.1038/nature08144 · Cited by 2,534
“The recent structures of opsin provide clues to the transmembrane helix rearrangements that can be expected as a result of agonist bindin”
Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists
Wu, B., Chien, E. Y. T., Mol, C. D., Fenalti, G., Liu, W., Katritch, V., Abagyan, R., Brooun, A., Wells, P., Bi, F. C., et al. (2010) · Science · doi:10.1126/science.1194396 · Cited by 1,782
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
“6 nM) was used as radioligand and agonist (2)-isoproterenol (ISO) or inverse agonist ICI-118,551 (ICI) as competitor.”
MethodMolecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
The Molecular Basis of G Protein–Coupled Receptor Activation
Weis, W. I., & Kobilka, B. K. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060614-033910 · Cited by 1,227
Microbial and Animal Rhodopsins: Structures, Functions, and Molecular Mechanisms
Ernst, O. P., Lodowski, D. T., Elstner, M., Hegemann, P., Brown, L. S., & Kandori, H. (2014) · Chemical Reviews · doi:10.1021/cr4003769 · Cited by 1,153
Self-citationStructure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
GPCRdb: an information system for G protein-coupled receptors
Isberg, V., Mordalski, S., Munk, C., Rataj, K., Harpsøe, K., Hauser, A. S., Vroling, B., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1178 · Cited by 1,072
“These have revealed mechanisms of orthosteric and allosteric (9) ligand binding, conformational changes upon receptor activation (10–12), and the modes of binding of G protein (13,14) and -arrestin (15) signal mediators.”
BackgroundActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
Self-citationStructure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
Methods of Protein Structure Comparison
Kufareva, I., & Abagyan, R. (2011) · Methods in Molecular Biology · doi:10.1007/978-1-61779-588-6_10 · Cited by 723
Structure and function of an irreversible agonist-β2 adrenoceptor complex
Rosenbaum, D. M., Zhang, C., Lyons, J. A., Holl, R., Aragao, D., Arlow, D. H., Rasmussen, S. G. F., Choi, H.-J., DeVree, B. T., Sunahara, R. K., et al. (2011) · Nature · doi:10.1038/nature09665 · Cited by 767
Biased Signaling Pathways in β 2 -Adrenergic Receptor Characterized by 19 F-NMR
Liu, J. J., Horst, R., Katritch, V., Stevens, R. C., & Wüthrich, K. (2012) · Science · doi:10.1126/science.1215802 · Cited by 697
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
“Importantly, this salt bridge is broken only in the active-state structures of β2AR-Gαβγ (18) and Opsin-GαCT (21), where R3.”
BackgroundCrystal structure of metarhodopsin II
Choe, H.-W., Kim, Y. J., Park, J. H., Morizumi, T., Pai, E. F., Krauß, N., Hofmann, K. P., Scheerer, P., & Ernst, O. P. (2011) · Nature · doi:10.1038/nature09789 · Cited by 663
Self-citationActivation mechanism of the β2-adrenergic receptor
Dror, R. O., Arlow, D. H., Maragakis, P., Mildorf, T. J., Pan, A. C., Xu, H., Borhani, D. W., & Shaw, D. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1110499108 · Cited by 623
“Crystal structures of meta II (active) rhodopsin and of opsin (both with and without the Gα C-terminal helix bound) display a similar arrangement of helices 5, 6, and 7 (5, 21, 22), except that the intracellular end of helix 6 is shifted approximately 5 Å farther from the helical bundle in the active structure of β2AR…”
BackgroundThe structural basis for agonist and partial agonist action on a β1-adrenergic receptor
Warne, T., Moukhametzianov, R., Baker, J. G., Nehmé, R., Edwards, P. C., Leslie, A. G. W., Schertler, G. F. X., & Tate, C. G. (2011) · Nature · doi:10.1038/nature09746 · Cited by 618
Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573
“It was only in 2008, when a crystal structure was solved for opsin associated with a carboxyl-terminal peptide fragment of its G subunit, transducin, that the first minimally active conformation of a family A 7TMR could be directly appreciated (Scheerer et al., 2008).”
GPCR Signaling Regulation: The Role of GRKs and Arrestins
Gurevich, V. V., & Gurevich, E. V. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00125 · Cited by 545
Structure of the Adenosine A2A Receptor in Complex with ZM241385 and the Xanthines XAC and Caffeine
Doré, A. S., Robertson, N., Errey, J. C., Ng, I., Hollenstein, K., Tehan, B., Hurrell, E., Bennett, K., Congreve, M., Magnani, F., et al. (2011) · Structure · doi:10.1016/j.str.2011.06.014 · Cited by 553
“…A2A receptor structural activation spectrum Structures of two receptors, rhodopsin and the β2-AR, have previously been obtained in both active (Rasmussen et al., 2011; Scheerer et al., 2008; Standfuss et al.,2011) and inactive conformations (Cherezov et al., 2007; Palczewski et al., 2000).”
BackgroundInfluentialNormal Mode Analysis of Biomolecular Structures: Functional Mechanisms of Membrane Proteins
Bahar, I., Lezon, T. R., Bakan, A., & Shrivastava, I. H. (2010) · Chemical Reviews · doi:10.1021/cr900095e · Cited by 537
G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery
Zhang, M., Chen, T., Lu, X., Lan, X., Chen, Z., & Lu, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01803-6 · Cited by 491
“37 The fi rst GPCR-G protein complex was determined in 2011 using X-ray diffraction; 38 however, the demanding nature of X-ray crystallography has rendered GPCR-G protein complex crystallization a dif fi cult undertaking.”
MethodThe Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Tao, Y.-X. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0037 · Cited by 531
Structure of the agonist-bound neurotensin receptor
White, J. F., Noinaj, N., Shibata, Y., Love, J., Kloss, B., Xu, F., Gvozdenovic-Jeremic, J., Shah, P., Shiloach, J., Tate, C. G., et al. (2012) · Nature · doi:10.1038/nature11558 · Cited by 509
Phototransduction Motifs and Variations
Yau, K.-W., & Hardie, R. C. (2009) · Cell · doi:10.1016/j.cell.2009.09.029 · Cited by 492
Regulation, signaling, and physiological functions of G-Proteins
Syrovatkina, V., Alegre, K. O., Dey, R., & Huang, X.-Y. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.08.002 · Cited by 498
“This dimer interface is similar to the one observed in the dimer of rhodopsin in the active state which uses TM1 and H8 as an interface [37, 38].”
The structural basis of agonist-induced activation in constitutively active rhodopsin
Standfuss, J., Edwards, P. C., D’Antona, A., Fransen, M., Xie, G., Oprian, D. D., & Schertler, G. F. X. (2011) · Nature · doi:10.1038/nature09795 · Cited by 476
Diversity and modularity of G protein-coupled receptor structures
Katritch, V., Cherezov, V., & Stevens, R. C. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.09.003 · Cited by 456
Action of Molecular Switches in GPCRs - Theoretical and Experimental Studies
Trzaskowski, B., Latek, D., Yuan, S., Ghoshdastider, U., Debinski, A., & Filipek, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320556 · Cited by 469
“These findings were confirmed later in similar study by Scheerer [91].”
ResultLigand-specific regulation of the extracellular surface of a G-protein-coupled receptor
Bokoch, M. P., Zou, Y., Rasmussen, S. G. F., Liu, C. W., Nygaard, R., Rosenbaum, D. M., Fung, J. J., Choi, H.-J., Thian, F. S., Kobilka, T. S., et al. (2010) · Nature · doi:10.1038/nature08650 · Cited by 470
Update on melatonin receptors: IUPHAR Review 20
Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13536 · Cited by 422
“MT2-melatonin Active rhodopsin (Scheerer et al., 2008) A3.”
Muscarinic acetylcholine receptors: novel opportunities for drug development
Kruse, A. C., Kobilka, B. K., Gautam, D., Sexton, P. M., Christopoulos, A., & Wess, J. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4295 · Cited by 437
G protein-coupled receptor kinases: More than just kinases and not only for GPCRs
Gurevich, E. V., Tesmer, J. J. G., Mushegian, A., & Gurevich, V. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.08.001 · Cited by 423
“Structure of opsin in complex with a peptide derived from the C-terminus of Gαt demonstrates its potential to bind amphipathic helices (Scheerer et al., 2008), such as those now known to be contained in GRKs and heterotrimeric G proteins.”
BackgroundStructure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain
Doré, A. S., Okrasa, K., Patel, J. C., Serrano-Vega, M., Bennett, K., Cooke, R. M., Errey, J. C., Jazayeri, A., Khan, S., Tehan, B., et al. (2014) · Nature · doi:10.1038/nature13396 · Cited by 410
Facilities for macromolecular crystallography at the Helmholtz-Zentrum Berlin
Mueller, U., Darowski, N., Fuchs, M. R., Förster, R., Hellmig, M., Paithankar, K. S., Pühringer, S., Steffien, M., Zocher, G., & Weiss, M. S. (2012) · Journal of Synchrotron Radiation · doi:10.1107/s0909049512006395 · Cited by 396
“Rhodopsin is a so-called G-protein coupled receptor or GPCR. GPCRs are seven-helix membrane proteins which are very important members of signal transduction pathways and primary targets for the pharmaceutical industry.”
Evolution of phototransduction, vertebrate photoreceptors and retina
Lamb, T. D. (2013) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2013.06.001 · Cited by 397
Impact of GPCR Structures on Drug Discovery
Congreve, M., de Graaf, C., Swain, N. A., & Tate, C. G. (2020) · Cell · doi:10.1016/j.cell.2020.03.003 · Cited by 375
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.011 · Cited by 365
“, 2016), opsin bound to a C-terminal peptide of transducin (Scheerer et al., 2008), and rhodopsin bound to visual arrestin (Kang et al.”
Overcoming barriers to membrane protein structure determination
Bill, R. M., Henderson, P. J. F., Iwata, S., Kunji, E. R. S., Michel, H., Neutze, R., Newstead, S., Poolman, B., Tate, C. G., & Vogel, H. (2011) · Nature Biotechnology · doi:10.1038/nbt.1833 · Cited by 373
A G protein-coupled receptor at work: the rhodopsin model
Hofmann, K. P., Scheerer, P., Hildebrand, P. W., Choe, H.-W., Park, J. H., Heck, M., & Ernst, O. P. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.07.005 · Cited by 376
Self-citationConformational changes in the G protein Gs induced by the β2 adrenergic receptor
Chung, K. Y., Rasmussen, S. G. F., Liu, T., Li, S., DeVree, B. T., Chae, P. S., Calinski, D., Kobilka, B. K., Woods, V. L., & Sunahara, R. K. (2011) · Nature · doi:10.1038/nature10488 · Cited by 365
Universal allosteric mechanism for Gα activation by GPCRs
Flock, T., Ravarani, C. N. J., Sun, D., Venkatakrishnan, A. J., Kayikci, M., Tate, C. G., Veprintsev, D. B., & Babu, M. M. (2015) · Nature · doi:10.1038/nature14663 · Cited by 365
Agonist-bound structure of the human P2Y12 receptor
Zhang, J., Zhang, K., Gao, Z.-G., Paoletta, S., Zhang, D., Han, G. W., Li, T., Ma, L., Zhang, W., Müller, C. E., et al. (2014) · Nature · doi:10.1038/nature13288 · Cited by 347
Designer proteins: applications of genetic code expansion in cell biology
Davis, L., & Chin, J. W. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3286 · Cited by 355
Chemistry of the Retinoid (Visual) Cycle
Kiser, P. D., Golczak, M., & Palczewski, K. (2014) · Chemical Reviews · doi:10.1021/cr400107q · Cited by 353
Ligand binding and micro-switches in 7TM receptor structures
Nygaard, R., Frimurer, T. M., Holst, B., Rosenkilde, M. M., & Schwartz, T. W. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.02.006 · Cited by 346
Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation
Han, Y., Moreira, I. S., Urizar, E., Weinstein, H., & Javitch, J. A. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.199 · Cited by 339
Mini-G proteins: Novel tools for studying GPCRs in their active conformation
Nehmé, R., Carpenter, B., Singhal, A., Strege, A., Edwards, P. C., White, C. F., Du, H., Grisshammer, R., & Tate, C. G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0175642 · Cited by 323
“The first active structure determined was of opsin stabilized at low pH [21] and bound to a C-terminal fragment of the G protein transducin [22].”
The GPCR Network: a large-scale collaboration to determine human GPCR structure and function
Stevens, R. C., Cherezov, V., Katritch, V., Abagyan, R., Kuhn, P., Rosen, H., & Wüthrich, K. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3859 · Cited by 316
“Additional structure reports include the characterization of the active and inactive states for rhodopsin 36 and opsin 37 , β 2 -AR 38–41 and adenosine A 2A receptor 18,42,43 .”
BackgroundLohse, M. J., Nuber, S., & Hoffmann, C. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004309 · Cited by 307
“The first is the elucidation of the structures of many GPCRs, encompassing both inactive and, more recently, active forms of the receptors, but also their downstream G-proteins (Rasmussen et al., 2007; Park et al., 2008; Scheerer et al., 2008; Rosenbaum et al., 2009, 2011; Choe et al., 2011b).”
BackgroundFribourg, M., Moreno, J. L., Holloway, T., Provasi, D., Baki, L., Mahajan, R., Park, G., Adney, S. K., Hatcher, C., Eltit, J. M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.055 · Cited by 311
Lifting the lid on GPCRs: the role of extracellular loops
Wheatley, M., Wootten, D., Conner, M., Simms, J., Kendrick, R., Logan, R., Poyner, D., & Barwell, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01629.x · Cited by 304
“, 2008) or complexed with a peptide corresponding to the C-terminal fragment of transducin Ga (GaCT; Scheerer et al., 2008).”
BackgroundDror, R. O., Arlow, D. H., Borhani, D. W., Jensen, M. Ø., Piana, S., & Shaw, D. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811065106 · Cited by 303
“On this basis (17), we suggest that the 2AR Asp-1303.”
BackgroundInfluentialG-protein-coupled receptor inactivation by an allosteric inverse-agonist antibody
Hino, T., Arakawa, T., Iwanari, H., Yurugi-Kobayashi, T., Ikeda-Suno, C., Nakada-Nakura, Y., Kusano-Arai, O., Weyand, S., Shimamura, T., Nomura, N., et al. (2012) · Nature · doi:10.1038/nature10750 · Cited by 296
Light sensing and responses in fungi
Yu, Z., & Fischer, R. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0109-x · Cited by 285
Signaling through G protein coupled receptors
Tuteja, N. (2009) · Plant Signaling & Behavior · doi:10.4161/psb.4.10.9530 · Cited by 253
Status of GPCR Modeling and Docking as Reflected by Community-wide GPCR Dock 2010 Assessment
Kufareva, I., Rueda, M., Katritch, V., Stevens, R. C., & Abagyan, R. (2011) · Structure · doi:10.1016/j.str.2011.05.012 · Cited by 281
“, 2000) and ligand-free (opsin) (Park et al., 2008; Scheerer et al., 2008) forms; human b2 (Cherezov et al.”
InfluentialRestructuring G-Protein- Coupled Receptor Activation
Audet, M., & Bouvier, M. (2012) · Cell · doi:10.1016/j.cell.2012.09.003 · Cited by 262
Energy Landscapes as a Tool to Integrate GPCR Structure, Dynamics, and Function
Deupi, X., & Kobilka, B. K. (2010) · Physiology · doi:10.1152/physiol.00002.2010 · Cited by 264
“50) can reach the extended conformation needed for binding of the G protein, as seen in the structure of activated opsin (40).”
Nanobodies to Study G Protein–Coupled Receptor Structure and Function
Manglik, A., Kobilka, B. K., & Steyaert, J. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104710 · Cited by 257
“To stabilize the active conformation of opsin for crystallography, previous studies utilized low pH (99, 100) and the C-terminal peptide of transducin (101).”
Tracking G-protein-coupled receptor activation using genetically encoded infrared probes
Ye, S., Zaitseva, E., Caltabiano, G., Schertler, G. F. X., Sakmar, T. P., Deupi, X., & Vogel, R. (2010) · Nature · doi:10.1038/nature08948 · Cited by 263
Crystal structure of oligomeric β1-adrenergic G protein–coupled receptors in ligand-free basal state
Huang, J., Chen, S., Zhang, J. J., & Huang, X.-Y. (2013) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2504 · Cited by 261
Functions, Therapeutic Applications, and Synthesis of Retinoids and Carotenoids
Álvarez, R., Vaz, B., Gronemeyer, H., & de Lera, Á. R. (2014) · Chemical Reviews · doi:10.1021/cr400126u · Cited by 260
Wootten, D., Simms, J., Miller, L. J., Christopoulos, A., & Sexton, P. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221585110 · Cited by 250
“60(190), consistent with helical movements that occur in family A GPCRs (26, 34).”
BackgroundMultiple ligand-specific conformations of the β2-adrenergic receptor
Kahsai, A. W., Xiao, K., Rajagopal, S., Ahn, S., Shukla, A. K., Sun, J., Oas, T. G., & Lefkowitz, R. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.634 · Cited by 250
The effect of ligand efficacy on the formation and stability of a GPCR-G protein complex
Yao, X. J., Vélez Ruiz, G., Whorton, M. R., Rasmussen, S. G. F., DeVree, B. T., Deupi, X., Sunahara, R. K., & Kobilka, B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811437106 · Cited by 246
“Crystal structures of G proteins have been obtained in both active and inactive states (4–6), and structures of bovine rhodopsin (7–12), squid rhodopsin (13, 14), bovine opsin (15, 16), the human 2AR (17–19), the turkey 1AR (20), and the adenosine A2a receptor (21) have been reported.”
BackgroundUncovering the intimate relationship between lipids, cholesterol and GPCR activation
Oates, J., & Watts, A. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.09.007 · Cited by 244
The role of protein dynamics in GPCR function: insights from the β2AR and rhodopsin
Manglik, A., & Kobilka, B. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.01.008 · Cited by 234
“In contrast, there are several active state structures of rhodopsin including ligand-free opsin and Meta II, crystallized both with and without Gαt-CT (Park, Scheerer et al. 2008, Scheerer, Park et al. 2008, Choe, Kim et al. 2011, Standfuss, Edwards et al. 2011).”
BackgroundHuman GLP-1 receptor transmembrane domain structure in complex with allosteric modulators
Song, G., Yang, D., Wang, Y., de Graaf, C., Zhou, Q., Jiang, S., Liu, K., Cai, X., Dai, A., Lin, G., et al. (2017) · Nature · doi:10.1038/nature22378 · Cited by 241
Stabilized G protein binding site in the structure of constitutively active metarhodopsin-II
Deupi, X., Edwards, P., Singhal, A., Nickle, B., Oprian, D., Schertler, G., & Standfuss, J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114089108 · Cited by 242
“Opsin has also been solved in complex with a peptide resembling the C-terminus of the G protein alpha subunit (GαCT), which provided the first molecular insights into how the G protein binds the active receptor (8).”
BackgroundStructural insights into agonist-induced activation of G-protein-coupled receptors
Deupi, X., & Standfuss, J. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.002 · Cited by 234
Angel, T. E., Chance, M. R., & Palczewski, K. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903545106 · Cited by 235
“In addition to ground-state bovine rhodopsin, these structures include inactive ligand free bovine opsin (10, 11), truncated squid rhodopsin (12), mutant human 2-adrenergic receptor T4-lysozyme fusion protein (13) and mutant 2-adrenergic receptor with Fab (14), mutant turkey 1-adrenergic receptor with antagonist bound…”
BackgroundNanobody stabilization of G protein-coupled receptor conformational states
Steyaert, J., & Kobilka, B. K. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.06.011 · Cited by 234
Melancon, B. J., Hopkins, C. R., Wood, M. R., Emmitte, K. A., Niswender, C. M., Christopoulos, A., Conn, P. J., & Lindsley, C. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201139r · Cited by 226
The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery
Salon, J. A., Lodowski, D. T., & Palczewski, K. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003350 · Cited by 222
“, 2006), ligand-free bovine opsin (Park et al., 2008; Scheerer et al., 2008), heterologously expressed constitutively active mutant rhodopsin (Standfuss et al.”
BackgroundInfluentialActivation and dynamic network of the M2 muscarinic receptor
Miao, Y., Nichols, S. E., Gasper, P. M., Metzger, V. T., & McCammon, J. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309755110 · Cited by 217
“for conformational transition between the inactive and active states of the M5 receptor (25), and similar structural rearrangements of TM5 and TM7 and the outward tilting of TM6 have been characterized in the active structures of rhodopsin (5, 6) and β2AR (7, 8).”
BackgroundInfluentialGPCRdb: the G protein‐coupled receptor database – an introduction
Munk, C., Isberg, V, Mordalski, S., Harpsøe, K., Rataj, K., Hauser, A. S., Kolb, P., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13509 · Cited by 211
“However, structures of fully activated receptorsaresofarlimited to complexes of β 2 -adrenoceptor to Gs (Rasmussen et al., 2011), opsin (activated rhodopsin) to β -arrestin (Kang et al., 2015), or a G t α -subunit C-terminus (Scheerer et al., 2008), and the μ”
BackgroundCryo-EM structure of the serotonin 5-HT1B receptor coupled to heterotrimeric Go
García-Nafría, J., Nehmé, R., Edwards, P. C., & Tate, C. G. (2018) · Nature · doi:10.1038/s41586-018-0241-9 · Cited by 217
CURRENT PROGRESS IN STRUCTURE-BASED RATIONAL DRUG DESIGN MARKS A NEW MINDSET IN DRUG DISCOVERY
Lounnas, V., Ritschel, T., Kelder, J., McGuire, R., Bywater, R. P., & Foloppe, N. (2013) · Computational and Structural Biotechnology Journal · doi:10.5936/csbj.201302011 · Cited by 213
Progress in Structure Based Drug Design for G Protein-Coupled Receptors
Congreve, M., Langmead, C. J., Mason, J. S., & Marshall, F. H. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200371q · Cited by 215
Gautier, A., Mott, H. R., Bostock, M. J., Kirkpatrick, J. P., & Nietlispach, D. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1807 · Cited by 212
“For the expression of pSRII(1-241)21 the psopII gene from Natronomonas pharaonis plus a sequence encoding a C-terminal (His)6-tag was inserted into the pET-28b(+) vector and transformed into the E.”
MethodEgloff, P., Hillenbrand, M., Klenk, C., Batyuk, A., Heine, P., Balada, S., Schlinkmann, K. M., Scott, D. J., Schütz, M., & Plückthun, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317903111 · Cited by 211
“Proc Natl Acad Sci USA 109(25):9810–9815.”
Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation
Ahuja, S., Hornak, V., Yan, E. C. Y., Syrett, N., Goncalves, J. A., Hirshfeld, A., Ziliox, M., Sakmar, T. P., Sheves, M., Reeves, P. J., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1549 · Cited by 213
Structures of membrane proteins
Vinothkumar, K. R., & Henderson, R. (2010) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000041 · Cited by 195
Structural waters define a functional channel mediating activation of the GPCR, rhodopsin
Angel, T. E., Gupta, S., Jastrzebska, B., Palczewski, K., & Chance, M. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901074106 · Cited by 203
A Lipid Pathway for Ligand Binding Is Necessary for a Cannabinoid G Protein-coupled Receptor
Hurst, D. P., Grossfield, A., Lynch, D. L., Feller, S., Romo, T. D., Gawrisch, K., Pitman, M. C., & Reggio, P. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041590 · Cited by 200
Discovery of New GPCR Biology: One Receptor Structure at a Time
Hanson, M. A., & Stevens, R. C. (2009) · Structure · doi:10.1016/j.str.2008.12.003 · Cited by 196
“…yielding to crystallization efforts (Cherezov et al., 2007; Jaakola et al., 2008; Rasmussen et al., 2007; Rosenbaum et al., 2007; Warne et al., 2008) and significant inroads made in resolving the activated state of bovine rhodopsin (Park et al., 2008; Scheerer et al., 2008) (Table 1; Figure 2).”
InfluentialWang, Y., Li, Z., Weber, T. J., Hu, D., Lin, C.-T., Li, J., & Lin, Y. (2013) · Analytical Chemistry · doi:10.1021/ac400858g · Cited by 196
Structure and Activation of the Visual Pigment Rhodopsin
Smith, S. O. (2010) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-101209-104901 · Cited by 192
Passing the baton in class B GPCRs: peptide hormone activation via helix induction?
Parthier, C., Reedtz-Runge, S., Rudolph, R., & Stubbs, M. T. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.02.004 · Cited by 191
Structural Basis for G Protein-Coupled Receptor Activation
Manglik, A., & Kruse, A. C. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00747 · Cited by 194
FTIR analysis of GPCR activation using azido probes
Ye, S., Huber, T., Vogel, R., & Sakmar, T. P. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.167 · Cited by 182
Structural insights into adrenergic receptor function and pharmacology
Kobilka, B. K. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.02.005 · Cited by 181
Hauser, M. A., & Legler, D. F. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0815-380r · Cited by 190
“Compared with active conformations of rhodopsin bound to GaCT peptides [80, 81], arrestin-bound rhodopsin shows additional subtle conformational differences in TM1, TM4, and TM7 [79].”
BackgroundThe Histamine H3 Receptor: Structure, Pharmacology, and Function
Nieto-Alamilla, G., Márquez-Gómez, R., García-Gálvez, A.-M., Morales-Figueroa, G.-E., & Arias-Montaño, J.-A. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.104752 · Cited by 185
“resolved (Scheerer et al., 2008), leading to a revolutionary”
BackgroundLigand-regulated oligomerization of β2-adrenoceptors in a model lipid bilayer
Fung, J. J., Deupi, X., Pardo, L., Yao, X. J., Velez-Ruiz, G. A., DeVree, B. T., Sunahara, R. K., & Kobilka, B. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.267 · Cited by 181
“…movement of TM6 (Gether et al, 1997; Ghanouni et al, 2001a, b; Yao et al, 2006) consistent with relatively large conformational changes observed in rhodopsin by DEER spectroscopy (Altenbach et al, 2008), and from the crystal structure of opsin (Park et al, 2008; Scheerer et al, 2008).”
The Structural Basis of G‐Protein‐Coupled Receptor Signaling (Nobel Lecture)
Kobilka, B. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302116 · Cited by 180
Crystal structure of pre-activated arrestin p44
Kim, Y. J., Hofmann, K. P., Ernst, O. P., Scheerer, P., Choe, H.-W., & Sommer, M. E. (2013) · Nature · doi:10.1038/nature12133 · Cited by 170
Self-citation
Metadata
- Authors
- Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Queen Mary University of London (GB)
- Humboldt-Universität zu Berlin (DE)
- Corresponding author
- Choe, Hui-Woog
- Hofmann, Klaus Peter
- Ernst, Oliver P.
- ORCID
- Venue
- Nature
- Published
- 2008-09
- Volume
- 455
- Issue
- 7212
- Pages
- 497-502
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989971979
- Cited by
- 1,059
- References
- 64
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 10 · 2023: 12 · 2022: 19 · 2021: 27 · 2020: 19 · 2019: 39 · 2018: 46 · 2017: 54 · 2016: 52 · 2015: 78 · 2014: 64 · 2013: 101 · 2012: 103
- FWCI
- 56.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- HZB Repository (Helmholtz-Zentrum Berlin für Materialien und Energie GmbH (HZB)) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Photoreceptor and optogenetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- opsin, rhodopsin, G protein-coupled receptors, G protein activation, G-protein binding site, beta-turn, NPxxY motif, retinal binding site, signal transduction mechanism
- MeSH terms
- Animals, Arginine, Binding Sites, Cattle, Crystallization, Models, Biological, Models, Molecular, Protein Conformation, Regeneration, Retinaldehyde, Rhodopsin, Signal Transduction, Conserved Sequence, Rod Opsins, Crystallography, X-Ray, Amino Acid Motifs, GTP-Binding Protein alpha Subunits
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.